agilon health, inc.
corporate_fare Company Profile
agilon health, inc. (NYSE:AGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for AGL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for AGL spans 8-K, 10-Q, DEFA14A, DEF 14A.
Recent high-impact activity:
- agilon Swings to $35M Q3 Profit, Lifts 2026 Adjusted EBITDA Guidance to $145-$155M
- agilon Swings to $35M Profit, Lifts Full-Year EBITDA Outlook to $145-155M
- agilon health Reports Strong Q1 Profitability Turnaround, Regains NYSE Compliance, and Details New CEO's Performance-Linked Equity
- agilon health Reports Strong Q1 Results, Significantly Raises Full-Year 2026 Revenue and Profit Guidance
- agilon health Appoints Tim O'Rourke as New CEO and President with Ambitious Stock Price Performance Incentives
Financial Snapshot
Short Interest & Short Volume
4.71 days to coverFINRA reported short interest of 846,737 shares in AGL as of the October 30, 2026 settlement, a 5.8% decrease from the prior period — about 4.7 days to cover at its recent average daily volume. On November 19, 2026, 60.7% of AGL volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.